Logo image
Back
Stimulating Young Minds: Investigating a Next Generation Treatment for Depression in Youth
Abstract   Peer reviewed

Stimulating Young Minds: Investigating a Next Generation Treatment for Depression in Youth

M Kaur, Daniel F Hermens, Rico S C Lee, Jim Lagopoulos, Sharon L Naismith, Paul Fitzgerald, Elizabeth Scott and Ian Hickie
Biological Psychiatry, Vol.83(9, Supplement 1), p.S407
Annual Scientific Convention and Meeting of the Society of Biological Psychiatry: Biomarkers, Biomodels, and Psychiatric Disorders, 73rd (New York, United States, 10-May-2018–12-May-2018)
2018
DOI: https://doi.org/10.1016/j.biopsych.2018.02.1044
url
https://doi.org/10.1016/j.biopsych.2018.02.1044View
Published Version

Abstract

Biological Sciences Psychology and Cognitive Sciences Medical and Health Sciences youth depression repetitive transcranial magnetic stimulation
Background: One third of young depressed patients do not respond to antidepressants and are at risk for chronic treatment resistance. Repetitive transcranial magnetic stimulation (rTMS) is efficacious in treating depression, however, few studies have investigated patients at earlier stages of illness when providing optimal treatments are likely to result in better response outcomes. A subset of patients show inadequate response to rTMS and identifying features of patients that predict response is needed to inform personalised approaches. Methods: In this open-label study, 17 young inpatients and outpatients with depression (aged 18-30; 22±3.8) were recruited. Neuronavigationally targeted high frequency (10 Hz) rTMS was administered at 110% of resting motor threshold on the left DLPFC for 45 trains of 4 seconds for 20 sessions over 4 weeks. Clinical interview, cognitive assessment and, psychosocial self-report scales were carried out within 2 weeks pre- and post-treatment. Results: Paired-samples t-tests revealed that depression, anxiety and psychiatric symptoms were significantly reduced with rTMS treatment (all p&.05) but no significant changes in cognitive or psychosocial functioning were found (p>.05). Greater improvements in depressive symptoms were associated with better pre-treatment set-shifting performance (p&.05; r=.53). In patients with moderate-severe depression (n=9), greater improvements in psychiatric symptoms were associated with later age of illness onset (p&.05; r=.88). Conclusions: In keeping with the literature, rTMS improves depressive, anxiety and psychiatric symptoms in young people. These data suggest that cognition may have utility in predicting rTMS treatment response and targeting rTMS earlier in the course of illness may result in better response outcomes in young people with depression.

Details

Metrics

2 File views/ downloads
634 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Neurosciences
Psychiatry
Logo image